BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17961389)

  • 1. [The experimental studies on cell transplantation into chronic ischemic myocardium using mesenchymal stem cells modified by recombinant adenovirus carrying vascular endothelial growth factors 165 gene].
    Gao CQ; Yang M; Li LB; Chen W; Hou LH; Li JM; Li B
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):990-3. PubMed ID: 17961389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of myocardial transplantation of mesenchymal stem cells transfected with vascular endothelial factor gene on improvement of heart function and angiogenesis after myocardial infarction: experiment with rats].
    Yang JF; Zhou WW; Tang T; Yu JF; Zhou XM; Hu JG
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(15):1027-34. PubMed ID: 16784704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction.
    Yang J; Zhou W; Zheng W; Ma Y; Lin L; Tang T; Liu J; Yu J; Zhou X; Hu J
    Cardiology; 2007; 107(1):17-29. PubMed ID: 16741354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell transplantation into ischemic myocardium using mesenchymal stem cells transfected by vascular endothelial growth factor.
    Hua P; Tao J; Liu JY; Yang SR
    Int J Clin Exp Pathol; 2014; 7(11):7782-8. PubMed ID: 25550816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction.
    Matsumoto R; Omura T; Yoshiyama M; Hayashi T; Inamoto S; Koh KR; Ohta K; Izumi Y; Nakamura Y; Akioka K; Kitaura Y; Takeuchi K; Yoshikawa J
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1168-73. PubMed ID: 15831811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model.
    Lim SY; Kim YS; Ahn Y; Jeong MH; Hong MH; Joo SY; Nam KI; Cho JG; Kang PM; Park JC
    Cardiovasc Res; 2006 Jun; 70(3):530-42. PubMed ID: 16563361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
    Tang J; Xie Q; Pan G; Wang J; Wang M
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction.
    Wang YQ; Wang M; Zhang P; Song JJ; Li YP; Hou SH; Huang CX
    Chin Med J (Engl); 2008 Nov; 121(22):2290-8. PubMed ID: 19080335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A promising strategy for the treatment of ischemic heart disease: Mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats.
    Gao F; He T; Wang H; Yu S; Yi D; Liu W; Cai Z
    Can J Cardiol; 2007 Sep; 23(11):891-8. PubMed ID: 17876381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis.
    Lu F; Zhao X; Wu J; Cui Y; Mao Y; Chen K; Yuan Y; Gong D; Xu Z; Huang S
    Int J Cardiol; 2013 Sep; 167(6):2524-32. PubMed ID: 22981278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of mesenchymal stem cells carrying the human receptor activity-modifying protein 1 gene improves cardiac function and inhibits neointimal proliferation in the carotid angioplasty and myocardial infarction rabbit model.
    Shi B; Long X; Zhao R; Liu Z; Wang D; Xu G
    Exp Biol Med (Maywood); 2014 Mar; 239(3):356-65. PubMed ID: 24477823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
    Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N
    Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wharton's jelly-derived mesenchymal stem cells promote myocardial regeneration and cardiac repair after miniswine acute myocardial infarction.
    Zhang W; Liu XC; Yang L; Zhu DL; Zhang YD; Chen Y; Zhang HY
    Coron Artery Dis; 2013 Nov; 24(7):549-58. PubMed ID: 23892469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction.
    Liu C; Fan Y; Zhou L; Zhu HY; Song YC; Hu L; Wang Y; Li QP
    Int J Cardiol; 2015 Jun; 188():22-32. PubMed ID: 25880576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway.
    Chen JJ; Zhou SH
    Cardiol J; 2011; 18(6):675-81. PubMed ID: 22113756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of MicroRNA-1 improves the efficacy of mesenchymal stem cell transplantation after myocardial infarction.
    Huang F; Li ML; Fang ZF; Hu XQ; Liu QM; Liu ZJ; Tang L; Zhao YS; Zhou SH
    Cardiology; 2013; 125(1):18-30. PubMed ID: 23615185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic induction of pro-angiogenic milieu after transplantation of marrow-derived mesenchymal stem cells in experimental myocardial infarction.
    Rahbarghazi R; Nassiri SM; Ahmadi SH; Mohammadi E; Rabbani S; Araghi A; Hosseinkhani H
    Int J Cardiol; 2014 May; 173(3):453-66. PubMed ID: 24679689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Umbilical Cord-Derived Mesenchymal Stromal Cells Improve Left Ventricular Function, Perfusion, and Remodeling in a Porcine Model of Chronic Myocardial Ischemia.
    Liu CB; Huang H; Sun P; Ma SZ; Liu AH; Xue J; Fu JH; Liang YQ; Liu B; Wu DY; Lü SH; Zhang XZ
    Stem Cells Transl Med; 2016 Aug; 5(8):1004-13. PubMed ID: 27334487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
    Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
    Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
    Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
    Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.